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We have developed a complementation assay, using transiently transfected COS cells, to facilitate a
molecular analysis of the herpes simplex virus type 1 glycoprotein gH. When infected by a gH-null syncytial
virus, COS cells expressing wild-type gH generate infectious progeny virions and form a syncytium with
neighboring cells. By deletion and point mutagenesis, we have found particular residues in the gH cytoplasmic
tail to be essential for generation of a syncytium but apparently dispensable for production of infectious
virions. This study emphasizes the different requirements for cell-cell and cell-envelope fusion and demon-
strates that changes in the non-syn locus UL22-gH can reverse the syncytial phenotype.
Herpes simplex virus type 1 (HSV-1) infection follows fusion
between the viral envelope and the cell plasma membrane
(PM), or endosomal membrane. The HSV-1 envelope contains
at least a dozen different membrane proteins, about 10 of
which are known to be glycosylated, and virus entry is abso-
lutely dependent on the activity of glycoproteins gB, gD, gH,
and gL. The products of UL53 (gK; see reference 23), UL25,
and an unknown number of other genes may also be required.
HSV-1 is believed also to be capable of direct spread from cell
to cell via intercellular junctions created by local fusion events
between the PMs of infected and uninfected cells. More
extensive cell fusion, resulting in polykaryocyte formation,
occurs when cells are infected with syncytial (syn) mutants,
which arise following repeated passage of virus in tissue culture
(for a comprehensive overview, see reference 43).
At least four different syn loci have been defined; UL20 (2,
30), UL24 (24, 42), UL53-gK (3, 22, 31, 37, 38), and UL27-gB
(7, 8, 15). It is unclear how such mutations result in formation
of syncytia; however, at least some of the UL20 and UL24 syn
mutations must result in failure to express the corresponding
protein. These gene products are therefore not required for
cell-cell fusion but may normally serve to down regulate it. In
contrast, deletion studies suggest that UL27-gB is required for
cell-cell fusion, as it is for envelope-PM fusion. Syncytial alleles
of UL27 generate gB proteins with an altered cytoplasmic tail
(15, 20) and range from alanine-to-valine substitutions (44) to
severe truncations (1). Such amino acid substitutions or trun-
cations presumably allow gB to participate in cell-cell fusion
even in the presence of the UL20 and UL24 products. As syn
mutations within UL53 are limited to missense mutations, gK,
like gB, may be essential for syncytium formation.
Gene deletion and antibody inhibition studies have sug-
gested that UL22-gH (18) and US6-gD (28, 36) are also
essential for cell-cell fusion. However, no mutations conferring
a syncytial phenotype have been described within either of
these genes (a syn mutation initially assigned to ULl has more
recently been found to reside within UL53 [29, 41]). Thus,
although there appears to be a common gB-gD-gH-gL-depen-
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dent apparatus for cell-cell and cell-envelope fusion, it remains
unclear how fusion occurs, how it is controlled, and to what
extent the various fusion-catalyzing glycoproteins contribute to
regulation.
Glycoprotein H is an approximately 110-kDa protein, pre-
dicted to have an N-terminal signal sequence and a single
membrane-spanning hydrophobic region close to the C termi-
nus (6, 11, 13, 14, 18). The amino-terminal bulk of gH is likely
to reside on the outside of the cell or virus since this region
contains all the consensus sites for N-linked glycosylation and
all of the mutations which confer resistance to anti-gH neu-
tralizing antibodies (16). In this orientation, a 14-amino-acid
C-terminal tail (KVLRTSVPFFWRRE in single-letter amino
acid code) projects towards the cell cytoplasm or viral capsid.
The external domain of gH associates with the 25-kDa glyco-
protein gL (21), and assembly of the gH-gL complex is
apparently essential for cell surface trafficking and envelope
incorporation of both proteins (12, 19, 39, 41).
We have developed a transient cell expression assay to
facilitate rapid molecular analysis of gH and have begun to
investigate which regions of the protein are required for the
various fusion events in which it participates. Surprisingly,
modification of the cytoplasmic tail of gH almost completely
abolishes the ability of gH to support syncytium formation by
a UL27-gB syn mutant but has little effect on the yield of
progeny virus or the rate at which mutant gH-containing
envelopes fuse with cells.
MATERIALS AND METHODS
Viruses and cells. Vero, F6, and COS7 cells were grown in
DMEM-FCS-PS: Dulbecco's modified Eagle's medium
(GIBCO Laboratories) supplemented with 10% fetal calf
serum (HyClone) and 1% penicillin-streptomycin (GIBCO).
F6 cells are a stably transformed Vero cell line which express
HSV-1 gH under the control of the HSV-1 gD promoter (13).
HSV-1 gH-gBANG is a derivative of SC16 which carries a syn
mutation in UL27 (44), resulting in an alanine-to-valine sub-
stitution in residue 855 of gB, and in which gH coding
sequences have been deleted and replaced by the Escherichia
coli lacZ gene. Construction of this virus will be reported
elsewhere. Stocks of virus were prepared by low-multiplicity
passage on F6 cells, and titers were determined by plaque assay
on F6 cells.
6985
Vol. 68, No. 11
 o
n
 N
ovem
ber 5, 2015 by University of Queensland Library
http://jvi.asm.org/
D
ow
nloaded from
 
6986 WILSON ET AL.
Transfection. COS7 cells were seeded into six-well plates to
approximately 30% confluence (about 105 cells per well),
grown for about 18 h, washed with prewarmed DMEM lacking
serum, and then overlaid with 0.4 ml of prewarmed transfec-
tion mixture (34) containing 0.2 ml of Optimem (GIBCO)-0.2
ml of 1-mg/ml DEAE-Dextran (Pharmacia) in Tris-buffered
saline (140 mM NaCl, 3 mM KCl, 25 mM Tris-Cl [pH 7.4]) and
1 jig of plasmid DNA. Plasmid DNA was omitted when mock
transfections were carried out. After 30 min at 37°C, the
mixture was removed and cells were overlaid with 3 ml of
DMEM-FCS-PS containing 100 p.g of chloroquine per ml.
After 3 to 4 h at 37°C, this overlay was replaced by DMEM
-FCS-PS and cells were incubated for 16 h prior to infection.
Transient expression assays. Transfected cells were infected
with 2 x 106 PFU of HSV-1 gH-gBANG in 0.2 ml of DMEM
-FCS-PS for 1 h at 37°C and then (with chilled solutions at all
times) washed in phosphate-buffered saline (PBS), treated for
1 min with 100 mM glycine (pH 3.0) or 135 mM NaCl-10 mM
KCl-40 mM citric acid (pH 3.0) (to inactivate unpenetrated
virus), and returned to neutral pH by being washed with PBS
and then a 1:1 mixture of PBS-DMEM. To screen for syncytial
or nonsyncytial phenotypes, the cells were then overlaid with 2
x 106 Vero cells. For quantitative analysis, the washed COS7
cells were trypsinized, suspended, and then titrated onto
preformed F6 or Vero monolayers. In both cases, after approx-
imately 16 h (Vero platings) or 36 to 48 h (F6 platings)
monolayers were fixed, permeabilized, stained to detect 3-ga-
lactosidase expression, and counterstained with neutral red as
previously described (13). To determine yields of infectious
virus, a portion of the trypsinized, washed COS cells was
replated into a tissue culture dish and incubated for a further
16 h to allow viral replication. The cells were subsequently
collected by scraping, and a sonicated extract was titrated onto
preformed F6 monolayers.
Rate of virus entIry. A known number of PFU were incu-
bated with preformed F6 monolayers for 2 h at 4°C to allow
adsorption. At various times after being shifted to 37°C,
unpenetrated virus was inactivated by acid treatment (as
described in "Transient expression assays"), incubation was
continued for 36 to 48 h, and plaques were scored. Total
plaque number (100% penetration) was determined from
samples which were not acid washed.
Western blotting (immunoblotting). Cell extracts were
boiled in Laemmli buffer and then subjected to denaturing
electrophoresis with a 7.5% polyacrylamide gel (27). Proteins
were transferred to nitrocellulose at 125 mA for 1 h with a
Hoefer semidry blotter and a transfer buffer identical to gel
electrophoresis buffer but supplemented with 25% methanol.
The filter was incubated for 1 h in blocking buffer (PBS-0.1%
Tween 20-3% dried milk) and then for 2 h with a 1:2,000
dilution of rabbit anti-gH polyclonal serum (prepared as
previously described [11]) in blocking buffer and washed for 20
min with four changes of PBS-0.1% Tween 20. After incuba-
tion with peroxidase-conjugated goat anti-rabbit immunoglob-
ulin G (Sigma) diluted 1:4,000 in blocking buffer, the filter was
washed as before, treated for 1 min with enhanced chemilu-
minescence reagent (Amersham), and exposed to Fuji X-ray
film for between 1 and 30 s.
Plasmids and UL22 mutagenesis. Plasmid pgHLmpSC11 (5)
was digested to release the HFEM gH gene as a 3.5-kb BglII
fragment. Sticky ends were blunted with the Klenow fragment
of DNA polymerase, and the DNA was ligated with EcoRV-
digested plasmid expression vector SMH3 to yield the gH
expression plasmid SMHgH1. Plasmid GEMHO was constructed
by ligating EcoRV-NsiI-digested plasmid GEM5ZF(+) (Pro-
mega) with an XmaI-NsiI synthetic linker (see below) and an
EcoRV-XmaI UL22 fragment derived from SMHgH1 and
corresponding to nucleotides 43974 (SmaI-XmaI site) to 44247
(EcoRV site) in the GenBank HE1CG sequence file of HSV-1
strain 17. This region of UL22 encodes gH residues 1-713 to
P-803 (single-letter amino acid code). The linker was prepared
by annealing the complementary oligonucleotides 5' CCGG
GATCGAATTCAGCATGCA and 5' TGCTGAATTCGATC
and contains an internal EcoRI cleavage site to aid in identi-
fication of recombinants.
Modified UL22 genes were prepared by replacing the 3' end
of UL22 in SMHgH1 with fragments generated by PCR with
the oligonucleotide primers 5' GCCGCAATTGCGCCCGGG
(a perfect match to the region of UL22 which includes the
SmaI-XmaI site at position 43974) and a mutagenic primer. All
mutagenic oligonucleotide primers begin with the sequence 5'
GCGCATGCATGTCTAGAGAATTCCTATTA to append
NsiI, XbaI, and EcoRI sites to the end of the PCR fragment
and encode two in-frame UL22 stop codons. For C-terminal
deletion of gH, mutagenic primers continued CGGGACACT
TGTCCGGAGAACCT'TTAG or TGTCCGGAGAACCTT
TAGGATGCCAGC, modifying the 3' end of UL22 to encode
KVLRTSVP or KVLRT, respectively. For combined deletion
and mutagenesis, primers continued with a derivative of the
sequence CGGGACACTTGTCCGGAGAACCl'I'AGGAT
GCCAGCCAGGGCGGC (corresponding to the region of
UL22 3' UTR
UL22-gH I I
BstXI XbaI
iS EcoRV XmaI/SmaI Stop HSV TK
cmw_ 3'UTR
I 04 2.1 kb - 0.27-] .1
kb kb
O.1 kb
Adenoviru
Promoter
SMHgHl (7.0 kb)
BstXI Stop
XbaI
EcoRV XmaI/SmaI
FIG. 1. Plasmids for expression of wild-type and mutant gH pro-
teins (not to scale). Plasmid SMHgH1 (top) contains the HFEM UL22
gene and 3' UTR flanked by the adenovirus major late promoter
(pointed black bar) and HSV thymidine kinase 3' UTR (black
rectangle). Positions and priming directions of mutagenic PCR oligo-
nucleotides are shown by small stippled bars and arrowheads. The
lower part of the figure indicates the structure of all mutant UL22
expression plasmids. The region of UL22 synthesized by PCR is
indicated by heavy cross-hatching, and the region contributed by
plasmid GEMHO (see Materials and Methods) is indicated by light
cross-hatching. Stop codons and relevant restriction sites are indicated.
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TABLE 1. UL22 deletions and mutations
Name of gH derivative Sequence of cytoplasmic tail
gH wild type............................KVLRTSVPFFWRRE
gHSVP.................................KVLRTSVP
gHASVP ...............................KVLRT
gHSVA................................KVLRTSVA
gHSAP.................................KVLRTSAP
gHiAVP................................KVLRTAVP
UL22 encodingi gH residues A-818 to P-832), except that the
underlined region was CGCGACACT, CGGGGCACT, or
CGGGACAGC (encoding KVLRTSVA, KVLRTSAP, and
KVLRTAVP, respectively). PCRs contained 20 pmol of each
primer, 20 ng of SMHgHl template DNA, 1 mM (each)
deoxynucleoside triphosphate, and 0.5 U of Taq DNA poly-
merase (Cetus) in the manufacturer's recommended buffer in
a final volume of 25 i±l. Reaction mixtures were overlaid with
mineral oil; subjected to 25 cycles of 940C for 0.5 min 550C for
1 min, and 720C for 0.5 min; and chased for 5 min at 720C, and
then the products were gel purified and used to replace the
corresponding region of wild-type UL22 in one of two ways. (a)
PCR products were cut with Nsil and Xmal and then ligated
with Nsil-Xmal-digested GEMHO, replacing the oligonucleo-
tide linker and reconstructing the UL22 reading frame from
the 1-713 codon onwards. This UL22 region was released with
BstXl and Xbal and then ligated with BstXI-XbaI-digested
SMHgHl. (b) PCR products were digested with Xbal and
Xmal and then ligated with BstXI-Xbal-digested SMHgHl and
the BstXI-Xmal UL22 fragment from GEMHO. Both cloning
strategies recreated a full-length mutated UL22 gene within
the SMH3 vector. All PCR-derived regions were checked by
DNA sequence analysis.
RESULTS
A trans complementation assay for wild-type and mutant gH
proteins. To facilitate molecular analysis of gH, we developed
a trans complementation assay, analogous to that described for
study of other HSV glycoproteins (9, 10), in which gH and
recombinant derivatives are expressed from a transfected
plasmid and gH-null virions provide all other gene products.
We chose COS7 monkey fibroblasts as the host cell, since they
can easily be transfected to a relatively high frequency (20 to
70%). Plasmid SMHgHl was constructed to express the UL22
open reading frame from the adenovirus major late promoter
(Fig. 1). In SMHgHl, the UL22 gene retains about 1.0 kb of
downstream DNA sequence, including all of the UL22 3'
untranslated region (UTR) and polyadenylation signal.
We began our analysis of gH functional domains by testing
the role of the short cytoplasmic tail in fusion. Using PCR and
mutagenic oligonucleotide primers, we amplified modified
versions of the 3' end of UL22 from SMHgHl. The PCR
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FIG. 2. Result of seeding a confluent Vero monolayer onto transfected-infected COS fibroblasts. COS cells were mock transfected with no
DNA (A) or with plasmids designed to express wild-type gH (B), gHSVP (C), or gHASVP (D). Infected cells and syncytia were stained for
13-galactosidase expression (dark regions). For gHASVP, very small syn-like regions or examples of apparent viral spread to neighboring Vero cells
were occasionally observed (e.g., in the stained cells immediately left of center in panel D). This was never observed in mock-transfected controls.
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gH SVP ASVP
B
gH SVP ASVP
C
0.4-
0.3fl
0.2-
gH SVP ASVP
FIG. 3. Quantitative measurements of ICs, virus yield, and syncytium formation for the gH mutants. COS cells were transfected to express each
of the forms of gH tested in Fig. 2 or were mock transfected as indicated below each graph. Cells from two wells of a six-well plate were pooled
and processed as follows. (A) Cells were titrated onto F6 monolayers to determine the number of productively infected cells (ICs). Numbers are
expressed as thousands of ICs per well of the six-well plate. (B) Cells were seeded into a tissue culture dish, and total virus yield was determined
after 16 h. PFU are normalized to ICs. (C) Cells were titrated onto Vero cells to determine the number of individual syncytia formed. Results are
expressed as the number of syn formed by each IC. Values reported are the means of data from duplicate transfection experiments.
product was then used to replace the corresponding wild-type
region of UL22 in SMHgH1 (Fig. 1). In all recombinant UL22
expression plasmids, the 3' UTR was derived from the HSV-1
thymidine kinase gene rather than from UL22 itself; however,
similar results were obtained for wild-type UL22 when fol-
lowed by either its own 3' UTR or that of thymidine kinase
(data not shown). UL22 deletions and mutations described in
this study are listed in Table 1.
Healthy, subconfluent COS cells were transfected with gH
expression plasmids by the DEAE-Dextran method and, after
an overnight incubation, were infected with a gH-gBANG
derivative of HSV-1 SC16 at a multiplicity of infection of 10
(the gH-gBANG virus was grown in F6 cells, able to provide
wild-type gH protein in trans), and then unpenetrated virus was
inactivated by acid treatment. To test for the ability of wild-
type or mutant gH molecules to support syncytium formation,
the COS cells were then overlaid with a sufficient number of
Vero cells to generate a confluent monolayer, and incubation
continued overnight. If the mutant gH expressed by the
transfected cells is able to complement the gH deficiency in the
infecting syncytial virus, those cells would be capable of fusing
with surrounding Vero cells and giving rise to a syncytium.
A region of the cytoplasmic tail of gH is required to permit
syncytium formation. COS-Vero monolayers were fixed and
then stained for regions of LacZ expression to visualize
infected cells and syncytia. Results are shown in Fig. 2. As
expected, mock-transfected COS cells did not support syncy-
tium formation (panel A) whilst cells expressing wild-type gH
did (panel B). Panel C shows that deletion of the cytoplasmic
tail to KVLRTSVP only slightly diminished the extent of
syncytium formation (similar results were observed when the
cytoplasmic tail was deleted to KVLRTSVPFFW [data not
shown]). Strikingly, deletion of three further amino acid resi-
dues, leaving the sequence KVLRT, almost completely abol-
ished syncytium formation (panel D).
To properly quantitate this effect, and to further investigate
the properties of the mutated gH molecules, we prepared
transfected-infected COS cells as before but then trypsinized
them, prepared a suspension, and processed it in several ways.
One aliquot was titrated onto preformed monolayers of F6
Vero cells, which provide wild-type gH in trans. Spread of even
genotypically gH- virions from COS to F6 thus results in a
plaque and makes it possible to count the number of COS
infectious centers (ICs) (i.e., those cells which had been
productively infected and transfected). Figure 3A shows that
there were only slight variations (less than twofold) in the
number of productively infected COS cells for each form of
gH, demonstrating that each is able to mediate spread of
infection from COS to F6 cells.
It was not possible to determine from the above experiment
whether the mechanism or efficiency of viral spread was
different for each of the forms of gH. We therefore next
examined whether any of the gH mutants were defective in
supporting the production of progeny virions. After seeding an
aliquot of the COS cell suspension into a tissue culture dish, we
allowed virus replication to proceed for 16 h and then titrated
a sonicated cell extract onto F6 cell monolayers and scored
plaque numbers. To take account of possible variations in the
efficiency with which transfected-infected cells were recovered
and replated after trypsinization, yield of progeny virus was
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FIG. 4. Rate of entry experiment for progeny virions bearing
mutant forms of gH. Progeny virions were prepared from the transient
expression assay, equal numbers of PFU were adsorbed to F6 mono-
layers in the cold, and then infection was allowed to proceed at 37°C
for various lengths of time (horizontal axis) before acid inactivation of
unpenetrated virus. The vertical axis shows the number of plaques
scored, expressed as a percentage of the number of PFU initially
adsorbed (determined from non-acid-washed controls). Samples and
the plaque number representing 100% penetration are as follows: gH
(149 plaques) (solid circles), gHSVP (163 plaques) (solid squares), and
gHASVP (117 plaques) (open triangles). All values are the means
derived from duplicate experiments.
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normalized to the number of productive cells resulting from
each transfection experiment. Figure 3B demonstrates that
similar yields of infectious virus were generated by each
productive cell for all the forms of gH tested.
Finally, to quantitate the frequency of syncytium formation
we titrated the COS suspension onto preformed Vero cell
monolayers to a sufficiently low density to count the number of
individual syncytia formed. The results, again normalized to
numbers of productive cells, are shown in Fig. 3C. As sug-
gested by the results of the qualitative assay, gH/SVP is
greatly reduced in its ability to generate syncytia: wild-type gH
and gHSVP expression supported generation of one syncytium
for every three to five productively infected cells; however, only
1 in 200 gHASVP-expressing productive cells generated a clear
syncytium.
Given that deletion of the SVP sequence had such a
dramatic effect upon cell-cell fusion, we were surprised to
observe only slight effects on virus yield (Fig. 3B). However, a
limitation of these assays was that unpenetrated virus was not
inactivated at the end of the 1-h infection period; even slowly
penetrating virions would therefore have eventually given rise
to plaques. We reasoned that if gHASVP was defective in
fusion, we might observe differences between it and gHSVP or
wild-type gH by examining the rate at which mutant gH-
containing virions were able to penetrate the PM of target
cells. To test this, we allowed virions containing various forms
of gH to adsorb to F6 monolayers for 2 h at 4°C and then
shifted them to 37°C for varying lengths of time before acid
inactivation of unpenetrated virus. The results are shown in
Fig. 4. The rate of entry of virions bearing gHASVP in their
envelopes is only slightly lower than that of those bearing
gHSVP or wild-type gH and suggests that gHASVP is not
seriously compromised in catalysis of envelope-PM fusion.
Alanine mutagenesis of the SVP sequence. Mutant proteins
gHSVP and gHASVP differ in both the sequence and the
length of their cytoplasmic tail. To test which of these charac-
teristics is important for syncytium formation, we constructed
plasmids to express gH mutants bearing an alanine residue in
place of the residue serine, valine, or proline (Table 1). These
plasmids were transfected into COS cells and assayed as before
for numbers of ICs, yield of progeny virus, rate of cell
penetration, and syn-forming ability. The results are summa-
rized in Fig. 5. As expected, substitution of any of the three
terminal residues of gHSVP by alanine has little effect upon
the number of ICs generated (panel A), the normalized yield
of progeny virus (panel B), or rate of penetration during
infection (panel C). However, unlike gH molecules terminat-
ing with SVP, SVA, or AVP, gHSAP is severely compromised
in its ability to support syncytium formation (panel D): the
number of productive cells able to form a syncytium falls from
at least 1 in 8 (for gHSVP) to 1 in 120 for gHSAP. Figure 6
shows a field of the syncytia resulting from attachment of
transfected-infected COS cells to Vero monolayers. We con-
clude that the gH cytoplasmic tail residue valine 831 is
important for syncytium formation, at least when residues
downstream of SVP are absent.
Expression of mutant gH molecules. We tested whether the
steady-state levels of mutant gH proteins might differ. Trans-
SVP SVA SAP AVP
FIG. 5. Quantitation of gH derivatives subjected to alanine point
mutagenesis in the SVP region. Measurements of ICs (A), virus yield
(B), and syncytium formation (D) were as described in the legend to
Fig. 3. The forms of gH tested were gHSVP, gHSVA, gHSAP, and
gHAVP or a no-DNA control, as indicated below each graph. Rate of
entry of progeny virions (C) was determined as described in the legend
to Fig. 4. In panel C, samples and the plaque numbers representing
100% penetration are as follows: gHSVP (442 plaques) (solid squares),
gHSVA (474 plaques) (open triangles), gHSAP (302 plaques) (open
circles), and gHAVP (402 plaques) (solid circles).
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FIG. 6. Result of titrating transfected-infected COS fibroblasts
onto Vero monolayers and visualizing as described in the legend to
Fig. 2. COS cells were transfected with plasmids to express gH or gH
derivatives as follows. (A) Mock transfection; (B) wild-type gH; (C)
gHSVP; (D) gHAvSVP; (E) gHSVA; (F) gHSAP; (G) gHAVP. For
gHASVP and gHSAP, very small syn-like regions or spread of virus to
neighboring cells was occasionally observed, but syncytia resembling
those in panels B, C, E, and G were never seen.
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FIG. 7. Western blot of transfected-infected COS cells. Extracts
were subjected to SDS-polyacrylamide gel electrophoresis, blotted to
nitrocellulose, and probed with a rabbit anti-gH polyclonal antiserum.
Extracts were from HSV-1 strain SC16-infected baby hamster kidney(BHK) cells (lane 1) or COS cells expressing no gH (lane 2), gHSVP(lane 3), gHSVA (lane 4), gHSAP (lane 5), or gHAVP (lane 6). The
previously observed gH-related band is indicated by the lower arrow
on the right of the figure. COS-specific forms of gH which run between
the forms observed in BHK cells are indicated by the upper right-hand
arrow. Arrowheads on the left of the picture represent the location of
prestained molecular mass markers (Bethesda Research Laboratories)
with masses of 105, 70, and 43 kDa.
fected-infected cell extracts expressing gHSVP, gHSVA, gH-
SAP, or gHiAVP, and containing between 1.9 x 106 and 2.6 x
106 PFU, were boiled in Laemmli buffer and subjected to
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis and then Western blotted and probed with an anti-gH
polyclonal serum (Fig. 7). The forms of gH observed in all
plasmid-containing samples resemble those detected by
Gompels and Minson (19), including a band antigenically
related to gH but migrating at approximately 85 kDa (lower
arrow). Although appearance of this band is clearly dependent
upon the presence of the gH gene (since it is absent in lane 2),
its origin is unknown. Higher-molecular-weight forms of gH
(indicated by the upper arrow), which run midway between the
most abundant forms of gH expressed in BHK cells, are also
visible, as previously shown (19). The amount of matured
gHSAP polypeptide may be slightly reduced compared with
the other forms of gH, but there are no gross differences in
either the abundance or the molecular weight of each gH
polypeptide.
DISCUSSION
In principle, syncytial strains of HSV-1 can be restored to a
nonsyncytial phenotype by reversion of their syn allele or by
complementation with sufficient dosage of the wild-type allele
(23). Our studies suggest that the syncytial phenotype can also
be suppressed by changes within a non-syn locus, even though
other aspects of virus infectivity may be unaltered.
It is unclear why changes within the cytoplasmic tail of gH
should affect its role in fusion. One possibility is that the tail
may mediate multimerization of gH, interaction of gH with the
cytoplasmic tails of other membrane proteins, or gH associa-
tion with soluble proteins. Although gH has not previously
been shown to multimerize or bind proteins other than gL,
such interactions could be transient or unstable under the
experimental conditions used. Alternatively, tail regions close
to the membrane may interact with viral envelope or PM lipids,
perturbing the inner leaflet of the bilayer and contributing to
fusion. In this regard, it is interesting that, despite limited
primary sequence identity, the gH proteins encoded by the
alphaherpesviruses HSV-1 and -2 (4), equine herpesviruses 1
and 4 (35, 40), bovine rhinotracheitis virus type 1 (33),
varicella-zoster virus (25, 32), and pseudorabies virus (26) all
contain two neutral, nonaromatic amino acids (ML or VL) in
the most membrane-proximal region of their cytoplasmic tail.
Moreover, all have a valine residue at a position equivalent to
valine 831 in HSV-1, with the exception of varicella-zoster
virus and pseudorabies virus, in which this residue is a serine.
The corresponding gH regions in nonalphaherpesviruses are
more diverged but do commonly contain hydrophobic or
aromatic residues (see reference 17).
When downstream sequences are deleted, the motif SVP
(and in particular the central residue, valine 831) appears to
become essential for syncytium formation. It may appear
surprising that deleting the SVP motif, or mutating valine 831
to the chemically similar amino acid alanine, should have such
profound effects. However, similar changes in HSV-1 fusion
glycoproteins are known to be sufficient to alter the syncytial
phenotype: alanine-to-valine mutations convert nonsyncytial
alleles of both UL53-gK (38) and UL27-gB (44) to syncytial
ones. It is important to note, however, that in none of these
cases were other regions of the gene product simultaneously
deleted. It will be interesting to determine the effect of
mutating valine 831 to alanine in the context of the full-length
gH tail and of substituting structurally similar amino acids such
as leucine at this position.
Why should a mutant gH molecule be much poorer at
supporting one form of fusion than another? An obvious
possibility is that cell-cell fusion and envelope-PM fusion
require gH to perform different tasks and that these depend
upon different residues in the gH tail. It is not unreasonable to
suggest that these two fusion processes may have different
requirements, since viral envelopes and cell surfaces differ in
their degree of curvature and likely also in their lipid, choles-
terol, and protein composition. It will be interesting to test
whether nonsyncytial virions bearing gHASVP or gHSAP are
diminished in their ability to spread directly from cell to cell (a
process believed to occur by formation of limited fusion
junctions between apposed PMs) or in their ability to induce
polykaryocyte formation in vivo.
An alternative explanation for the observed results is that
the ASVP and SAP mutations result in a generally defective or
unstable gH polypeptide. There would then be insufficient
active gH on the PM to allow syncytia to form but presumably
enough to generate functional progeny: perhaps virions re-
quire relatively few active gH molecules in their envelopes to
efficiently penetrate cell membranes. There were no apparent
gross differences in the total steady-state levels of each gH
polypeptide expressed in these cells, but we cannot exclude the
possibility that the cell surface level of gHSAP is below some
threshold critical for cell-cell fusion to occur. PM gH could
also fall below this threshold level if the cytoplasmic tail
mutations interfered with its intracellular trafficking, reducing
the amount of gHASVP or gHSAP delivered to the cell
surface. Recruitment of active gH into viral envelopes (be-
lieved to be derived from internal membranes) would be
unaffected, leading to normal levels of fully infectious progeny.
Although fluorescence immunocytochemistry using anti-gH
antibodies suggested that all forms of gH reached the cell
surface (data not shown), these studies were nonquantitative; a
proper test of this possibility will require both quantitative
cell-surface immunocytochemical studies and detailed exami-
nation of the rate of maturation of each recombinant form of
gH.
This complementation assay will greatly facilitate a molecu-
lar analysis of gH and enable us to rapidly define those regions
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of the molecule important for cell-cell and virus-cell fusion. It
will also be interesting to test whether changes within gH can
inhibit syncytial phenotypes resulting from syn mutations other
than gBANG and to what extent. Different degrees of suppres-
sion might make it possible to group syn mutations in a
particular locus into weak or strong alleles and also help
distinguish among the roles of different syn loci in generation
of the syncytial phenotype.
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